Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Scott Louis Cohen is active.

Publication


Featured researches published by Scott Louis Cohen.


ACS Medicinal Chemistry Letters | 2013

Metabolically Stable tert-Butyl Replacement

David Barnes-Seeman; Monish Jain; Leslie Bell; Suzie Ferreira; Scott Louis Cohen; Xiaohui Chen; Jakal Amin; Brad Snodgrass; Panos Hatsis

Susceptibility to metabolism is a common issue with the tert-butyl group on compounds of medicinal interest. We demonstrate an approach of removing all the fully sp(3) C-Hs from a tert-butyl group: replacing some C-Hs with C-Fs and increasing the s-character of the remaining C-Hs. This approach gave a trifluoromethylcyclopropyl group, which increased metabolic stability. Trifluoromethylcyclopropyl-containing analogues had consistently higher metabolic stability in vitro and in vivo compared to their tert-butyl-containing counterparts.


Archive | 2011

BICYCLIC ACETYL-COA CARBOXYLASE INHIBITORS

David Barnes; Gregory Raymond Bebernitz; Kevin B. Clairmont; Scott Louis Cohen; Robert E. Damon; Robert Francis Day; Stephanie Kay Dodd; Christoph Gaul; Efthymiou Hatice Belgin Gulgeze; Monish Jain; Rajeshri Ganesh Karki; Louise Kirman; Kai Lin; Justin Yik Ching Mao; Tajesh Jayprakash Patel; Brian Kenneth Raymer; Liansheng Su


Archive | 2010

Cyclohexane derivatives as inhibitors of acetyl-coa carboxylase (acc)

David Barnes; Gregory Raymond Bebernitz; Scott Louis Cohen; Robert E. Damon; Robert Francis Day; Monish Jain; Rajeshri Ganesh Karki; Louise Kirman; Tajesh Jayprakash Patel; Brian Kenneth Raymer; Herbert F. Schuster; Wei Zhang


Archive | 2010

Cyclohexane derivatives and uses thereof

David Barnes; Gregory Raymond Bebernitz; Scott Louis Cohen; Robert E. Damon; Robert Francis Day; Monish Jain; Rajeshri Ganesh Karki; Louise Kirman; Tajesh Jayprakash Patel; Brian Kenneth Raymer; Herbert F. Schuster; Wei Zhang


Archive | 2011

BICYCLIC ACETYL-COA CARBOXYLASE INHIBITORS AND USES THEREOF

David Barnes; Gregory Raymond Bebernitz; Kevin B. Clairmont; Scott Louis Cohen; Robert E. Damon; Robert Francis Day; Stephanie Kay Dodd; Christoph Gaul; Hatice Belgin Gulgeze Efthymiou; Monish Jain; Rajeshri Ganesh Karki; Louise Kirman; Kai Lin; Justin Yik Ching Mao; Tajesh Jayprakash Patel; Brian Kenneth Raymer; Liansheng Su


Archive | 2014

Substituted bisphenyl butanoic phosphonic acid derivatives as nep (neutral endopeptidase) inhibitors

David Barnes; Scott Louis Cohen; Dean F. Rigel


Archive | 2018

NOVEL 3' END CAPS, 5' END CAPS AND COMBINATIONS THEREOF FOR THERAPEUTIC RNA

David Barnes-Seeman; Scott Louis Cohen; John Louis Diener; Christian Gampe; James Roache; Amy White; Sarah Williams; Jun Yuan; Frédéric Zecri


Archive | 2016

End capped nucleic acid molecules

David Barnes-Seeman; Scott Louis Cohen; John Louis Diener; Christian Gampe; James Roache; Amy White; Sarah Williams; Jun Yuan; Frédéric Zecri


Archive | 2015

Substituted bisphenyl butanoic phosphonic acid derivatives as NEP inhibitors

David Barnes; Scott Louis Cohen; Dean F. Rigel


Archive | 2014

Substituierte butterphosphonsäurederivate als nep (neutrale endopeptidase)-inhibitoren

David Barnes; Scott Louis Cohen; Dean F. Rigel

Collaboration


Dive into the Scott Louis Cohen's collaboration.

Researchain Logo
Decentralizing Knowledge